Bristol-Myers Squibb Company (BMY): Favorite for Conservative Portfolios [Yahoo! Finance]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Yahoo! Finance
Bristol-Myers Squibb Company (NYSE:BMY) remains a favorite for conservative portfolios due to its exceptionally low volatility and its status as a high-yield income fortress. In a year marked by geopolitical tension and oil-driven market swings, the stock has served as a critical shock absorber for investors. It currently boasts one of the lowest betas in the S&P 500. This means it is roughly 73% less volatile than the broader market. As a major provider of life-saving oncology, cardiovascular, and immunology drugs, demand for the products marketed by the firm is decoupled from economic cycles. For example, patients do not stop taking medicines like Eliquis or Opdivo during a recession. Is enGene Holdings Inc. (ENGN) the Best Canadian Penny Stock to Invest in Now? Bristol-Myers Squibb Company (NYSE:BMY) is a top pick for income-focused funds because of its generous and reliable payout. Following the quarterly dividend of $0.63 per share paid in early 2026, the stock offers a sign
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company [Yahoo! Finance]Yahoo! Finance
- Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug CompanyBusiness Wire
- Bristol Myers Squibb: Strong Pipeline, Weak Outlook (Rating Downgrade) [Seeking Alpha]Seeking Alpha
- Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration [Yahoo! Finance]Yahoo! Finance
- Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration [TheStreet.com]TheStreet.com
BMY
Earnings
- 2/6/26 - Beat
BMY
Sec Filings
- 4/17/26 - Form DEFA14A
- 4/2/26 - Form 4
- 4/2/26 - Form 4
- BMY's page on the SEC website